SYNDROMES ASSOCIATED WITH CONOTRUNCAL DEFECTS  

 

Conotruncal anomalies are malformations of the great vessels, arising from the embryological structures of the conus and truncus, and account for about 30% of congenital heart defects (CHD).

·        Associated extracardiac anomalies, typically affecting the neck and head, result in apparently different clinical syndromes:

o       DiGeorge (DGS),

o       Shprintzen,

o       Velo-cardio-facial syndrome (VCFS)

o       Conotruncal anomaly face syndromes.

·        A microdeletion of 22q11.2 has been shown to be associated with these anomalies in greater than 80% of cases (1,2).

·        The syndromes have been grouped together under the acronym 'CATCH-22'  (3).

o       Cardiac defects,

o       Abnormal facies,

o       Thymus aplasia or hypoplasia,

o       Cleft palate,

o       Hypocalcemia,

o       22 denoting the deletion on chromosome 22.

o       Mental retardation, immunologic deficiency, hypocalcemia and other mild to severe disease are associated with CATCH-22.

o       Recently it was suggested to abandon the acronym CATCH-22 and instead to use mainly deletion 22q11.2 (4).

 

 

Frequency of
microdeletions of 22q11

1. Isolated (non familial).

20-30%  

2. Syndromes associated with thymic and facial anomalies:

  • "Conotruncal anomaly face"
    • hypotelorism
    • short palpebral fissures
    • low nasal bridge
    • ear lobe abnormalities
    • mild mental retardation
  • Velocardiofacial syndrome (VCFS)
    • cleft palate
    • typical facial appearance
    • learning disabilities
  • DiGeorge syndrome
    • typical facial appearance
    • thymic hypoplasia
    • hypocalcemia.

 
 
 
 
 
 
 
 
 
68-76%
 
 
 
83-88%  

 

22q11.2 DELETION AND CHD

 

·        The prevalence of del.22q11.2 in the general population is high (1:4000 live births) (5).

·        The prevalence in pediatric cardiology series depends on the specific subgroups examined.

o       Marino et al. (6) found that 88 of 931 (9.4%) infants and children with CHD examined for this purpose had a microdeletion. One case only had an isolated cardiac defect; the remaining 87 demonstrated features of DiGeorge/VCFS, such as facial anomalies, immune defects, palatal anomalies, neonatal hypocalcemia and mental retardation. Prenatal ultrasound has obvious limitations for most of these features, but our study has indicated that an absent or hypoplastic thymus may be a useful additional marker for the deletion.

·        In utero, the fetal thymus is well developed and is easily visualized with high resolution ultrasound (7).  It is best visualized in the 'three-vessel' view, a plane commonly used in assessment of fetal conotruncal and aortic arch lesions (8). As absence and hypoplasia of the thymus is associated with CATCH-22, it is possible that visualization of the thymus on ultrasound can be used as a marker in the detection of del.22q11.2.

o       There is a sensitivity of 90% in prediction of the 22q11.2 deletion when the fetal thymus is hypoplastic or absent, in association with a cardiac anomaly.

o       The thymus may be used as a sonographic marker to identify a group with CHD in whom targeted examination of del.22q11.2 is indicated (9).

·        The prevalence of 22q11.2 in a recent study was:

o        6.7% in all cardiac anomalies with normal karyotype,

o       13.1% in the subgroup with conotruncal anomalies.

·        The deletion is frequently found in:

o       interrupted aortic arch, particularly type B (45%),

o       absent pulmonary valve syndrome (50%) ) Johnson et al. (10), Iserin et al (11) and Boudjemline et al (12) that absent pulmonary valve syndrome comprises over 40% of cases associated with 22q11.2 deletion).

o       truncus arteriosus communis (30%),

o       pulmonary atresia with VSD (21%)

o       tetralogy of Fallot (14%) (11,13).

o         occasionally present in double outlet right ventricle (13) and transposition of the great arteries (14) and can be an incidental finding in non-conotruncal anomalies such as hypoplastic left heart syndrome (15), isomerism (16) or others.

 

 

Chaoui (17)

(prenatal)

= 76

(%)

Boudjemline  (12)

prenatal)

= 261

(%)

Iserin  (11)

(neonatal)

= 104

(%)

Goldmuntz  (13)

(pediatric)

n = 251

(%)

Interruption of the aortic arch

66.7

45.4

89

50

Truncus arteriosus

33.3

31.0

41

34.5

Absent pulmonary valve syndrome

50.0

37.5

40

 

Tetralogy of Fallot

9.0

14.0

26

15.9

Pulmonary atresia with VSD

0

21.5

46

 

Double outlet right ventricle

0

Not assessed

Not assessed

5

Transposition of the great arteries

0

Not assessed

Not assessed

0

Complex malpositions

0

0

Not assessed

Not assessed

VSD with conal septum malalignment

Not assessed

Not assessed

67

33.3

 

 

 

REFERENCES

 

  1. Driscoll DA. Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 1994; 6: 702-706.
  2. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30: 813-817
  3. Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet 1993; 30: 852-856
  4. Burn J. Closing time for CATCH22. J Med Genet 1999; 36: 737-738
  5. Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 1998; 35: 789-790
  6. Marino B, Digilio MC, Toscano A, Anaclerio S, Giannotti A, Feltri C, de Ioris MA, Angioni A, Dallapiccola B. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med 2001; 3: 45-48
  7. Felker RE, Cartier MS, Emerson DS, Brown DL. Ultrasound of the fetal thymus. J Ultrasound Med 1989; 8: 669-673
  8. Chaoui R. The examination of the normal fetal heart using two-dimensional echocardiography. In: Yagel S, Silvermann N, Gembruch U, eds. Fetal Cardiology. New York: Lippincott, 2002
  9. Chaoui R, Korner H, Bommer C. Prenatal assessment of the thymus in detecting fetuses with del.22q11. Ultrasound Obstet Gynecol 2000; 16: P-82
  10. Johnson MC, Hing A, Wood MK, Watson MS. Chromosome abnormalities in congenital heart disease. Am J Med Genet 1997; 70: 292-298
  11. Iserin L, de Lonlay P, Viot G, Sidi D, Kachaner J, Munnich A, Lyonnet S, Vekemans M, Bonnet D. Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies. Eur J Pediatr 1998; 157: 881-884
  12. Boudjemline Y, Fermont L, Le Bidois J, Lyonnet S, Sidi D, Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr 2001; 138: 520-524
  13. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, McDonald-McGinn D, Chien P, Feuer J, Zackai EH, Emanuel BS, Driscoll DA. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32: 492-498
  14. Marino B, Digilio MC, Toscano A, Anaclerio S, Giannotti A, Feltri C, de Ioris MA, Angioni A, Dallapiccola B. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med 2001; 3: 45-48
  15. Consevage MW, Seip JR, Belchis DA, Davis AT, Baylen BG, Rogan PK. Association of a mosaic chromosomal 22q11 deletion with hypoplastic left heart syndrome. Am J Cardiol 1996; 77: 1023-1025
  16. Yates RW, Raymond FL, Cook A, Sharland GK. Isomerism of the atrial appendages associated with 22q11 deletion in a fetus. Heart 1996; 76: 548-549
  17. Chaoui R, Kalache KD, Heling LS et.al. Absent or hypoplastic thymus on ultrasound: a marker for deletion 22q11.2 in fetal cardiac defects. Ultrasound Obstet gynecol 2002;20:546-552.